Elevance Health, Inc. (NYSE:ELV) Receives $509.44 Consensus Target Price from Brokerages
Elevance Health, Inc. (NYSE:ELV – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the seventeen ratings firms that are covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1-year price objective among […]
Elevance Health, Inc. (NYSE:ELV – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the seventeen ratings firms that are covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1-year price objective among […]
